Exousia Bio, Inc. (LMMY)
OTCMKTS · Delayed Price · Currency is USD
0.0190
-0.0001 (-0.52%)
Sep 9, 2026, 2:22 PM EST
Exousia Bio Revenue
In the fiscal year ending May 31, 2025, Exousia Bio had annual revenue of $3.75K, down -67.39%.
Revenue
3.75K
Revenue Growth
-67.39%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
1.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 3.75K | -7.75K | -67.39% |
| May 31, 2024 | 11.50K | - | - |
| May 31, 2023 | - | - | - |
| May 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Exousia Bio News
- 5 weeks ago - Exousia Bio Nearing Completion of Milestone Multimillion-Dollar Capital Investment - Accesswire
- 9 months ago - Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms - Accesswire
- 9 months ago - LAMY Completes Strategic Acquisition of Cancer Therapy Innovator Exousia AI, Inc. - GlobeNewsWire
- 9 months ago - Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value - Accesswire
- 1 year ago - LAMY Inc. Accelerates Strategic Upgrades, Deepens Global Presence and Technological Innovation - Accesswire
- 1 year ago - LAMY Unveils GenZ Financial Literacy Initiative Powered by User-Generated Content and Creator Economy Tools - Accesswire
- 1 year ago - LAMY Discusses The Smart Education Market Entering a Golden Era of Growth - Accesswire
- 1 year ago - L A M Y Announces Groundbreaking Advancements, Leading the Future of Education-Gaming Integration - Accesswire